Dale Westwood an Insider in QNB Corp. (QNBC) Sold 450 Shares of the Company; Ampio Pharmaceuticals (AMPE) Has 2.3 Sentiment

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company has market cap of $242.67 million. The firm is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. It currently has negative earnings. The Company’s product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema.

Dale Westwood is the Exec VP/Chief Retail Officer of Qnb Corp. He a few days ago unloaded 450 shares in the Pinksheet-listed company with the deal value totalling close to $20,025 U.S. Dollars. That was according to the filed price of $44.5 per each share. Dale Westwood now holds 0.12% of the total market cap of Qnb Corp.

The stock decreased 2.39% or $0.07 during the last trading session, reaching $2.86. About 212,088 shares traded. Ampio Pharmaceuticals, Inc. (AMPE) has declined 79.44% since March 26, 2017 and is downtrending. It has underperformed by 96.14% the S&P500.

Knoll Capital Management Lp holds 1.38% of its portfolio in Ampio Pharmaceuticals, Inc. for 2.60 million shares. Noven Financial Group Inc. owns 245,667 shares or 0.09% of their US portfolio. Moreover, Cypress Capital Management Llc (Wy) has 0.05% invested in the company for 72,000 shares. The Colorado-based Ghp Investment Advisors Inc. has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 15,037 shares.

QNB Corp. operates as the holding company for QNB Bank that provides commercial and retail banking services for the residents and businesses in southeastern Pennsylvania. The company has market cap of $152.98 million. It offers various deposit products, which include demand and savings accounts, such as money market accounts, interest-bearing demand accounts, club accounts, traditional statement savings accounts, and online savings accounts; and time deposit products comprising certificates of deposit and individual retirement accounts. It has a 18.38 P/E ratio. The firm also provides commercial and industrial loans, commercial and residential real estate loans, construction loans, indirect lease financing, family residential mortgage loans, home equity loans and lines of credit, and consumer loans.

The stock decreased 0.45% or $0.2 during the last trading session, reaching $44.3. About 180 shares traded. QNB Corp. (OTCMKTS:QNBC) has 0.00% since March 26, 2017 and is . It has underperformed by 16.70% the S&P500.